Maximus (NYSE:MMS) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?

Key Points

• Maximus shares moved above their 200-day moving average, reaching $66.78 and last trading near $66.53, compared with the moving average of $64.98.
• Analyst sentiment remains cautious: ratings currently average “Hold”, with recent changes including an upgrade from “Strong Sell” and a downgrade from “Buy.”
• The company slightly beat quarterly EPS expectations but missed revenue estimates, while revenue declined 5.1% year over year. Maximus also declared a quarterly dividend of $0.33, representing a 2.0% annualized yield.

Maximus, Inc. (NYSE:MMS - Get Free Report) passed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $64.98 and traded as high as $66.78. Maximus shares last traded at $66.5310, with a volume of 501,693 shares changing hands.

Analysts Set New Price Targets

MMS has been the topic of a number of analyst reports. Zacks Research raised Maximus from a "strong sell" rating to a "hold" rating in a research report on Thursday, October 1st. Weiss Ratings restated a "hold (c-)" rating on shares of Maximus in a research note on Monday, August 17th. Finally, Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Two research analysts have rated the stock with a Hold rating. According to MarketBeat, the stock currently has an average rating of "Hold".

Maximus Stock Performance

The stock's 50-day moving average is $58.09 and its 200-day moving average is $64.98. The firm has a market capitalization of $3.48 billion, a price-to-earnings ratio of 9.83 and a beta of 0.59. The company has a current ratio of 2.42, a quick ratio of 2.42 and a debt-to-equity ratio of 0.90.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, beating analysts' consensus estimates of $2.21 by $0.01. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%. The business's revenue for the quarter was down 5.1% on a year-over-year basis. During the same period last year, the firm posted $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, analysts predict that Maximus, Inc. will post 8.03 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date is Friday, November 13th. Maximus's dividend payout ratio (DPR) is presently 19.50%.

Insider Activity at Maximus

In other Maximus news, insider Michelle Link sold 3,208 shares of the firm's stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $54.23, for a total value of $173,969.84. Following the completion of the sale, the insider owned 13,881 shares of the company's stock, valued at approximately $752,766.63. This trade represents a 18.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.80% of the stock is currently owned by corporate insiders.

Institutional Trading of Maximus

Institutional investors and hedge funds have recently modified their holdings of the stock. CenterBook Partners LP purchased a new position in Maximus during the 3rd quarter valued at about $256,000. Chicago Partners Investment Group LLC purchased a new stake in Maximus in the third quarter worth about $337,000. Covestor Ltd grew its holdings in Maximus by 33.2% in the third quarter. Covestor Ltd now owns 2,199 shares of the health services provider's stock worth $117,000 after purchasing an additional 548 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Maximus in the third quarter worth about $36,000. Finally, Vise Technologies Inc. bought a new position in shares of Maximus during the third quarter valued at approximately $556,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

About Maximus

Maximus, Inc NYSE: MMS is a government services company that helps public-sector agencies administer health and human services, employment and workforce programs, and other citizen-focused operations. Its work includes eligibility and enrollment support, customer contact centers, case management, program administration, and technology-enabled services.

The company also provides services to government agencies involved in federal programs, including health care administration, workforce development, child support, and other public assistance initiatives.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.